-
1
-
-
84892678278
-
Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis
-
Eichenfield L.F., Tom W.L., Chamlin S.L., Feldman S.R., Hanifin J.M., Simpson E.L., et al. Guidelines of care for the management of atopic dermatitis: Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014, 70:338-351.
-
(2014)
J Am Acad Dermatol
, vol.70
, pp. 338-351
-
-
Eichenfield, L.F.1
Tom, W.L.2
Chamlin, S.L.3
Feldman, S.R.4
Hanifin, J.M.5
Simpson, E.L.6
-
2
-
-
84901809097
-
Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful
-
Tang T.S., Bieber T., Williams H.C. Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful. J Allergy Clin Immunol 2014, 133:1615-1625.
-
(2014)
J Allergy Clin Immunol
, vol.133
, pp. 1615-1625
-
-
Tang, T.S.1
Bieber, T.2
Williams, H.C.3
-
3
-
-
0030987778
-
The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4
-
Imai T. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4. J Biol Chem 1997, 272:15036-15042.
-
(1997)
J Biol Chem
, vol.272
, pp. 15036-15042
-
-
Imai, T.1
-
4
-
-
0035098042
-
Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity
-
Kakinuma T., Nakamura K., Wakugawa M., Mitsui H., Tada Y., Saeki H., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001, 107:535-541.
-
(2001)
J Allergy Clin Immunol
, vol.107
, pp. 535-541
-
-
Kakinuma, T.1
Nakamura, K.2
Wakugawa, M.3
Mitsui, H.4
Tada, Y.5
Saeki, H.6
-
5
-
-
0036968994
-
Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis
-
Fujisawa T., Fujisawa R., Kato Y., Nakayama T., Morita A., Katsumata H., et al. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. J Allergy Clin Immunol 2002, 110:139-146.
-
(2002)
J Allergy Clin Immunol
, vol.110
, pp. 139-146
-
-
Fujisawa, T.1
Fujisawa, R.2
Kato, Y.3
Nakayama, T.4
Morita, A.5
Katsumata, H.6
-
6
-
-
70349944005
-
Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis
-
Fujisawa T., Nagao M., Hiraguchi Y., Katsumata H., Nishimori H., Iguchi K., et al. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Pediatr Allergy Immunol 2009, 20:633-641.
-
(2009)
Pediatr Allergy Immunol
, vol.20
, pp. 633-641
-
-
Fujisawa, T.1
Nagao, M.2
Hiraguchi, Y.3
Katsumata, H.4
Nishimori, H.5
Iguchi, K.6
-
7
-
-
84896344225
-
Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis
-
Kataoka Y. Thymus and activation-regulated chemokine as a clinical biomarker in atopic dermatitis. J Dermatol 2014, 41:221-229.
-
(2014)
J Dermatol
, vol.41
, pp. 221-229
-
-
Kataoka, Y.1
-
8
-
-
79959590879
-
Japanese guideline for atopic dermatitis
-
Katayama I., Kohno Y., Akiyama K., Ikezawa Z., Kondo N., Tamaki K., et al. Japanese guideline for atopic dermatitis. Allergol Int 2011, 60:205-220.
-
(2011)
Allergol Int
, vol.60
, pp. 205-220
-
-
Katayama, I.1
Kohno, Y.2
Akiyama, K.3
Ikezawa, Z.4
Kondo, N.5
Tamaki, K.6
-
9
-
-
33745331786
-
Cytokines and chemokines orchestrate atopic skin inflammation
-
Homey B., Steinhoff M., Ruzicka T., Leung D.Y. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 2006, 118:178-189.
-
(2006)
J Allergy Clin Immunol
, vol.118
, pp. 178-189
-
-
Homey, B.1
Steinhoff, M.2
Ruzicka, T.3
Leung, D.Y.4
-
10
-
-
1142285210
-
Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis
-
Hijnen D., De Bruin-Weller M., Oosting B., Lebre C., De Jong E., Bruijnzeel-Koomen C., et al. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis. J Allergy Clin Immunol 2004, 113:334-340.
-
(2004)
J Allergy Clin Immunol
, vol.113
, pp. 334-340
-
-
Hijnen, D.1
De Bruin-Weller, M.2
Oosting, B.3
Lebre, C.4
De Jong, E.5
Bruijnzeel-Koomen, C.6
-
11
-
-
33644837166
-
The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis
-
Mitsuishi K., Nakamura T., Sakata Y., Yuyama N., Arima K., Sugita Y., et al. The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis. Clin Exp Allergy 2005, 35:1327-1333.
-
(2005)
Clin Exp Allergy
, vol.35
, pp. 1327-1333
-
-
Mitsuishi, K.1
Nakamura, T.2
Sakata, Y.3
Yuyama, N.4
Arima, K.5
Sugita, Y.6
-
12
-
-
85027957024
-
Periostin levels correlate disease severity and chronicity in patients with atopic dermatitis
-
Kou K., Okawa T., Yamaguchi Y., Ono J., Inoue Y., Kohno M., et al. Periostin levels correlate disease severity and chronicity in patients with atopic dermatitis. Br J Dermatol 2014, 171:283-291.
-
(2014)
Br J Dermatol
, vol.171
, pp. 283-291
-
-
Kou, K.1
Okawa, T.2
Yamaguchi, Y.3
Ono, J.4
Inoue, Y.5
Kohno, M.6
-
13
-
-
38549165090
-
Th1/Th2 cytokines reciprocally regulate in vitro pulmonary angiogenesis via CXC chemokine synthesis
-
Matsuda A., Fukuda S., Matsumoto K., Saito H. Th1/Th2 cytokines reciprocally regulate in vitro pulmonary angiogenesis via CXC chemokine synthesis. Am J Respir Cell Mol Biol 2008, 38:168-175.
-
(2008)
Am J Respir Cell Mol Biol
, vol.38
, pp. 168-175
-
-
Matsuda, A.1
Fukuda, S.2
Matsumoto, K.3
Saito, H.4
-
14
-
-
78650634417
-
IL-33 mediates inflammatory responses in human lung tissue cells
-
Yagami A., Orihara K., Morita H., Futamura K., Hashimoto N., Matsumoto K., et al. IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol 2010, 185:5743-5750.
-
(2010)
J Immunol
, vol.185
, pp. 5743-5750
-
-
Yagami, A.1
Orihara, K.2
Morita, H.3
Futamura, K.4
Hashimoto, N.5
Matsumoto, K.6
-
15
-
-
0037291211
-
Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro
-
Tsuda T., Tohyama M., Yamasaki K., Shirakata Y., Yahata Y., Tokumaru S., et al. Lack of evidence for TARC/CCL17 production by normal human keratinocytes in vitro. J Dermatol Sci 2003, 31:37-42.
-
(2003)
J Dermatol Sci
, vol.31
, pp. 37-42
-
-
Tsuda, T.1
Tohyama, M.2
Yamasaki, K.3
Shirakata, Y.4
Yahata, Y.5
Tokumaru, S.6
-
16
-
-
84887495747
-
Cell type-dependent effects of corticosteroid on periostin production by primary human tissue cells
-
Shoda T., Futamura K., Kobayashi F., Saito H., Matsumoto K., Matsuda A. Cell type-dependent effects of corticosteroid on periostin production by primary human tissue cells. Allergy 2013, 68:1467-1470.
-
(2013)
Allergy
, vol.68
, pp. 1467-1470
-
-
Shoda, T.1
Futamura, K.2
Kobayashi, F.3
Saito, H.4
Matsumoto, K.5
Matsuda, A.6
-
17
-
-
84903303598
-
Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies
-
Eichenfield L.F., Tom W.L., Berger T.G., Krol A., Paller A.S., Schwarzenberger K., et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol 2014, 71:116-132.
-
(2014)
J Am Acad Dermatol
, vol.71
, pp. 116-132
-
-
Eichenfield, L.F.1
Tom, W.L.2
Berger, T.G.3
Krol, A.4
Paller, A.S.5
Schwarzenberger, K.6
-
18
-
-
27144538707
-
Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin
-
Komine M., Kakinuma T., Kagami S., Hanakawa Y., Hashimoto K., Tamaki K. Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin. J Invest Dermatol 2005, 125:491-498.
-
(2005)
J Invest Dermatol
, vol.125
, pp. 491-498
-
-
Komine, M.1
Kakinuma, T.2
Kagami, S.3
Hanakawa, Y.4
Hashimoto, K.5
Tamaki, K.6
-
19
-
-
0033584358
-
The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells
-
Campbell J.J., Haraldsen G., Pan J., Rottman J., Qin S., Ponath P., et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature 1999, 400:776-780.
-
(1999)
Nature
, vol.400
, pp. 776-780
-
-
Campbell, J.J.1
Haraldsen, G.2
Pan, J.3
Rottman, J.4
Qin, S.5
Ponath, P.6
-
20
-
-
33745341560
-
Role of vasculature in atopic dermatitis
-
Steinhoff M., Steinhoff A., Homey B., Luger T.A., Schneider S.W. Role of vasculature in atopic dermatitis. J Allergy Clin Immunol 2006, 118:190-197.
-
(2006)
J Allergy Clin Immunol
, vol.118
, pp. 190-197
-
-
Steinhoff, M.1
Steinhoff, A.2
Homey, B.3
Luger, T.A.4
Schneider, S.W.5
-
21
-
-
84863539707
-
Periostin promotes chronic allergic inflammation in response to Th2 cytokines
-
Masuoka M., Shiraishi H., Ohta S., Suzuki S., Arima K., Aoki S., et al. Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest 2012, 122:2590-2600.
-
(2012)
J Clin Invest
, vol.122
, pp. 2590-2600
-
-
Masuoka, M.1
Shiraishi, H.2
Ohta, S.3
Suzuki, S.4
Arima, K.5
Aoki, S.6
-
22
-
-
0031893264
-
Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4
-
Imai T., Chantry D., Raport C.J., Wood C.L., Nishimura M., Godiska R., et al. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem 1998, 273:1764-1768.
-
(1998)
J Biol Chem
, vol.273
, pp. 1764-1768
-
-
Imai, T.1
Chantry, D.2
Raport, C.J.3
Wood, C.L.4
Nishimura, M.5
Godiska, R.6
-
23
-
-
33749370210
-
Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis
-
Hashimoto S., Nakamura K., Oyama N., Kaneko F., Tsunemi Y., Saeki H., et al. Macrophage-derived chemokine (MDC)/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci 2006, 44:93-99.
-
(2006)
J Dermatol Sci
, vol.44
, pp. 93-99
-
-
Hashimoto, S.1
Nakamura, K.2
Oyama, N.3
Kaneko, F.4
Tsunemi, Y.5
Saeki, H.6
-
24
-
-
42549123345
-
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment
-
Wollenberg A., Reitamo S., Girolomoni G., Lahfa M., Ruzicka T., Healy E., et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008, 63:742-750.
-
(2008)
Allergy
, vol.63
, pp. 742-750
-
-
Wollenberg, A.1
Reitamo, S.2
Girolomoni, G.3
Lahfa, M.4
Ruzicka, T.5
Healy, E.6
-
25
-
-
55949126332
-
Corticosteroid enhances TNF-alpha-mediated leukocyte adhesion to pulmonary microvascular endothelial cells
-
Matsuda A., Orihara K., Fukuda S., Fujinaga H., Matsumoto K., Saito H. Corticosteroid enhances TNF-alpha-mediated leukocyte adhesion to pulmonary microvascular endothelial cells. Allergy 2008, 63:1610-1616.
-
(2008)
Allergy
, vol.63
, pp. 1610-1616
-
-
Matsuda, A.1
Orihara, K.2
Fukuda, S.3
Fujinaga, H.4
Matsumoto, K.5
Saito, H.6
-
26
-
-
78249235035
-
Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis
-
Fukuie T., Nomura I., Horimukai K., Manki A., Masuko I., Futamura M., et al. Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis. Br J Dermatol 2010, 163:1127-1129.
-
(2010)
Br J Dermatol
, vol.163
, pp. 1127-1129
-
-
Fukuie, T.1
Nomura, I.2
Horimukai, K.3
Manki, A.4
Masuko, I.5
Futamura, M.6
-
27
-
-
79953668221
-
Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities
-
Suárez-Fariñas M., Tintle S.J., Shemer A., Chiricozzi A., Nograles K., Cardinale I., et al. Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J Allergy Clin Immunol 2011, 127:954-964.
-
(2011)
J Allergy Clin Immunol
, vol.127
, pp. 954-964
-
-
Suárez-Fariñas, M.1
Tintle, S.J.2
Shemer, A.3
Chiricozzi, A.4
Nograles, K.5
Cardinale, I.6
-
28
-
-
0037342141
-
Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung
-
Fukuda K., Fujitsu Y., Seki K., Kumagai N., Nishida T. Differential expression of thymus- and activation-regulated chemokine (CCL17) and macrophage-derived chemokine (CCL22) by human fibroblasts from cornea, skin, and lung. J Allergy Clin Immunol 2003, 111:520-526.
-
(2003)
J Allergy Clin Immunol
, vol.111
, pp. 520-526
-
-
Fukuda, K.1
Fujitsu, Y.2
Seki, K.3
Kumagai, N.4
Nishida, T.5
-
29
-
-
77955885245
-
Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCAM-1 in human corneal fibroblasts
-
Adachi T., Fukuda K., Kondo Y., Nishida T. Inhibition by tranilast of the cytokine-induced expression of chemokines and the adhesion molecule VCAM-1 in human corneal fibroblasts. Invest Ophthalmol Vis Sci 2010, 51:3954-3960.
-
(2010)
Invest Ophthalmol Vis Sci
, vol.51
, pp. 3954-3960
-
-
Adachi, T.1
Fukuda, K.2
Kondo, Y.3
Nishida, T.4
-
30
-
-
0037059328
-
The IKK-2/Ikappa Balpha/NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha-deficient mice
-
Huber M.A., Denk A., Peter R.U., Weber L., Kraut N., Wirth T. The IKK-2/Ikappa Balpha/NF-kappa B pathway plays a key role in the regulation of CCR3 and eotaxin-1 in fibroblasts. A critical link to dermatitis in Ikappa Balpha-deficient mice. J Biol Chem 2002, 277:1268-1275.
-
(2002)
J Biol Chem
, vol.277
, pp. 1268-1275
-
-
Huber, M.A.1
Denk, A.2
Peter, R.U.3
Weber, L.4
Kraut, N.5
Wirth, T.6
-
31
-
-
0036280939
-
Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils
-
Wong C.K., Zhang J.P., Ip W.K., Lam C.W. Activation of p38 mitogen-activated protein kinase and nuclear factor-kappaB in tumour necrosis factor-induced eotaxin release of human eosinophils. Clin Exp Immunol 2002, 128:483-489.
-
(2002)
Clin Exp Immunol
, vol.128
, pp. 483-489
-
-
Wong, C.K.1
Zhang, J.P.2
Ip, W.K.3
Lam, C.W.4
-
32
-
-
0141569203
-
The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes
-
Holvoet S., Vincent C., Schmitt D., Serres M. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-alpha in human keratinocytes. Exp Cell Res 2003, 290:108-119.
-
(2003)
Exp Cell Res
, vol.290
, pp. 108-119
-
-
Holvoet, S.1
Vincent, C.2
Schmitt, D.3
Serres, M.4
|